Rockwell Medical, Inc.

NasdaqCM:RMTI Stock Report

Market Cap: US$67.2m

Rockwell Medical Management

Management criteria checks 2/4

Rockwell Medical's CEO is Mark Strobeck, appointed in Jul 2022, has a tenure of 2.42 years. total yearly compensation is $1.05M, comprised of 53.7% salary and 46.3% bonuses, including company stock and options. directly owns 0.06% of the company’s shares, worth $40.50K. The average tenure of the management team and the board of directors is 2.3 years and 4.5 years respectively.

Key information

Mark Strobeck

Chief executive officer

US$1.1m

Total compensation

CEO salary percentage53.7%
CEO tenure2.4yrs
CEO ownership0.06%
Management average tenure2.3yrs
Board average tenure4.5yrs

Recent management updates

Recent updates

Rockwell Medical, Inc.'s (NASDAQ:RMTI) 28% Dip In Price Shows Sentiment Is Matching Revenues

Nov 15
Rockwell Medical, Inc.'s (NASDAQ:RMTI) 28% Dip In Price Shows Sentiment Is Matching Revenues

Rockwell Medical, Inc. (NASDAQ:RMTI) Analysts Just Trimmed Their Revenue Forecasts By 15%

Nov 14
Rockwell Medical, Inc. (NASDAQ:RMTI) Analysts Just Trimmed Their Revenue Forecasts By 15%

The Market Lifts Rockwell Medical, Inc. (NASDAQ:RMTI) Shares 28% But It Can Do More

Sep 29
The Market Lifts Rockwell Medical, Inc. (NASDAQ:RMTI) Shares 28% But It Can Do More

Rockwell Medical: The Turnaround Is Looking Real

Sep 15

Rockwell Medical, Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates

Aug 11
Rockwell Medical, Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates

Rockwell Medical, Inc.'s (NASDAQ:RMTI) Subdued P/S Might Signal An Opportunity

Jul 12
Rockwell Medical, Inc.'s (NASDAQ:RMTI) Subdued P/S Might Signal An Opportunity

Does Rockwell Medical (NASDAQ:RMTI) Have A Healthy Balance Sheet?

May 08
Does Rockwell Medical (NASDAQ:RMTI) Have A Healthy Balance Sheet?

Is Rockwell Medical (NASDAQ:RMTI) A Risky Investment?

Feb 06
Is Rockwell Medical (NASDAQ:RMTI) A Risky Investment?

Rockwell Medical, Inc. (NASDAQ:RMTI) Doing What It Can To Lift Shares

Dec 25
Rockwell Medical, Inc. (NASDAQ:RMTI) Doing What It Can To Lift Shares

Is Rockwell Medical (NASDAQ:RMTI) Using Too Much Debt?

Oct 11
Is Rockwell Medical (NASDAQ:RMTI) Using Too Much Debt?

Is Rockwell Medical (NASDAQ:RMTI) Weighed On By Its Debt Load?

Jun 02
Is Rockwell Medical (NASDAQ:RMTI) Weighed On By Its Debt Load?

Is There Now An Opportunity In Rockwell Medical, Inc. (NASDAQ:RMTI)?

Oct 25
Is There Now An Opportunity In Rockwell Medical, Inc. (NASDAQ:RMTI)?

An Intrinsic Calculation For Rockwell Medical, Inc. (NASDAQ:RMTI) Suggests It's 46% Undervalued

Sep 02
An Intrinsic Calculation For Rockwell Medical, Inc. (NASDAQ:RMTI) Suggests It's 46% Undervalued

Rockwell Medical Q2 Earnings Preview

Aug 12

Rockwell Medical: Triferic Remains Key Despite Sluggish Growth Profile

Mar 02

Rockwell Medical: Down But By No Means Out

Oct 05

CEO Compensation Analysis

How has Mark Strobeck's remuneration changed compared to Rockwell Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$1m

Jun 30 2024n/an/a

-US$5m

Mar 31 2024n/an/a

-US$9m

Dec 31 2023US$1mUS$566k

-US$9m

Sep 30 2023n/an/a

-US$9m

Jun 30 2023n/an/a

-US$12m

Mar 31 2023n/an/a

-US$13m

Dec 31 2022US$978kUS$267k

-US$19m

Compensation vs Market: Mark's total compensation ($USD1.05M) is above average for companies of similar size in the US market ($USD654.40K).

Compensation vs Earnings: Mark's compensation has increased whilst the company is unprofitable.


CEO

Mark Strobeck (53 yo)

2.4yrs

Tenure

US$1,054,169

Compensation

Dr. Mark Strobeck, Ph D., serves as Independent Director at Windtree Therapeutics, Inc. since June 2023 and is its Lead Independent Director since August 13, 2024. He has served as the President, Chief Exe...


Leadership Team

NamePositionTenureCompensationOwnership
Mark Strobeck
President2.4yrsUS$1.05m0.060%
$ 40.5k
Jesse Neri
Chief Financial Officer1.2yrsUS$453.18kno data
Megan Timmins
Executive VP3.3yrsUS$660.29k0.034%
$ 23.1k
Timothy Chole
Senior VP & Chief Commercial Officerless than a yearno data0.028%
$ 18.7k
Heather Hunter
Senior VP & Chief Corporate Affairs Officer2.3yrsno datano data

2.3yrs

Average Tenure

51yo

Average Age

Experienced Management: RMTI's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Mark Strobeck
President2.4yrsUS$1.05m0.060%
$ 40.5k
John Cooper
Independent Director7.3yrsUS$142.27k0.11%
$ 72.0k
Robert Radie
Independent Chairman4.8yrsUS$170.00k0.10%
$ 68.0k
Allen Nissenson
Independent Director4.5yrsUS$127.94k0.098%
$ 66.1k
Joan Lau
Independent Director1.2yrsUS$89.51k0.0062%
$ 4.2k
Mark Ravich
Independent Director7.5yrsUS$128.29k0.27%
$ 182.2k
Andrea Smiley
Independent Director4yrsUS$130.56k0.097%
$ 65.0k

4.5yrs

Average Tenure

61yo

Average Age

Experienced Board: RMTI's board of directors are considered experienced (4.5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 10:01
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Rockwell Medical, Inc. is covered by 16 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tazeen AhmadBofA Global Research
Jonathan AschoffBrean Capital
Ritu BaralCanaccord Genuity